Abstract:RIPC ameliorated brain edema induced by high‐altitude hypoxia through stimulating glucose metabolism down to the TCA cycle to boost mitochondrial ATP production. This finding supports the potential of RIPC as a viable therapeutic approach for the prevention and treatment of HACE, targeting metabolic reprogramming. This figure was created with BioRender (https://www.biorender.com). Aims Incidence of acute mountain sickness (AMS) ranges from 40%–90%, with high‐altitude cerebral edema (HACE) representing a life‐threatening end stage of severe AMS. However, practical and convenient preventive strategies for HACE are lacking. Remote ischemic preconditioning (RIPC) has demonstrated preventive effects on ischemia‐ or hypoxia‐induced cardiovascular and cerebrovascular diseases. This study aimed to investigate the potential molecular mechanism of HACE and the application of RIPC in preventing HACE onset. Methods A hypobaric hypoxia chamber was used to simulate a high‐altitude environment of 7000 meters. Metabolomics and metabolic flux analysis were employed to assay metabolite levels. Transcriptomics and quantitative real‐time PCR (q‐PCR) were used to investigate gene expression levels. Immunofluorescence staining was performed on neurons to label cellular proteins. The fluorescent probes Mito‐Dendra2, iATPSnFR1.0, and CMTMRos were used to observe mitochondria, ATP, and membrane potential in cultured neurons, respectively. TUNEL staining was performed to detect and quantify apoptotic cell death. Hematoxylin and eosin (H&E) staining was utilized to analyze pathological changes, such as tissue swelling in cerebral cortex samples. The Rotarod test was performed to assess motor coordination and balance in rats. Oxygen–glucose deprivation (OGD) of cultured cells was employed as an in vitro model to simulate the hypoxia and hypoglycemia induced by RIPC in animal experiments. Results We revealed a causative perturbation of glucose metabolism in the brain preceding cerebral edema. Ischemic preconditioning treatment significantly reprograms glucose metabolism, ameliorating cell apoptosis and hypoxia‐induced energy deprivation. Notably, ischemic preconditioning improves mitochondrial membrane potential and ATP production through enhanced glucose‐coupled mitochondrial metabolism. In vivo studies confirm that RIPC alleviates cerebral edema, reduces cell apoptosis induced by high‐altitude hypoxia, and improves motor dysfunction resulting from cerebral edema. Conclusions Our study elucidates the metabolic basis of HACE pathogenesis. This study provides a new strategy for preventing HACE that RIPC reduces brain edema through reprogramming metabolism, highlighting the potential of targeting metabolic reprogramming for neuroprotective interventions in neurological diseases caused by ischemia or hypoxia.

Role of intermittent hypoxic training combined with methazolamide in the prevention of high-altitude cerebral edema in rats

Combined Postischemic Hypothermia And Delayed Mk-801 Treatment Attenuates Neurobehavioral Deficits Associated With Transient Global-Ischemia In Rats

Effect of Hypoxia on Expression of AQP4 and HIF-1αin Protein in Prefrontal Cortex of Rats

Remote ischemic preconditioning prevents high‐altitude cerebral edema by enhancing glucose metabolic reprogramming

Intermittent Hypoxia Training Effectively Protects Against Cognitive Decline Caused by Acute Hypoxia Exposure.

Eleutheroside B alleviates oxidative stress and neuroinflammation by inhibiting the JAK2/STAT3 signaling pathway in a rat high altitude cerebral edema model

Ethyl 3,4-dihydroxybenzoate (EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain

Huperzine A Ameliorates Cognitive Deficits and Oxidative Stress in the Hippocampus of Rats Exposed to Acute Hypobaric Hypoxia

Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia

Development and Study of Rat Model of High Altitude Pulmonary Edema

Mechanism of Aquaporin 4 (AQP 4) Up-Regulation in Rat Cerebral Edema under Hypobaric Hypoxia and the Preventative Effect of Puerarin

High-Altitude Cognitive Impairment Is Prevented by Enriched Environment Including Exercise via VEGF Signaling

Preconditioning with Intermittent Hypobaric Hypoxia Attenuates Stroke Damage and Modulates Endocytosis in Residual Neurons.

Chronic Intermittent Hybobaric Hypoxia Protects Against Cerebral Ischemia Via Modulation of Mitokatp

Memantine ameliorates cognitive impairment induced by exposure to chronic hypoxia environment at high altitude by inhibiting excitotoxicity

Huperzine A Relieves Acute Hypobaric Hypoxic-Induced Oxidative Stress Injury in Rat Brain

Tetrahydrocurcumin Mitigates Acute Hypobaric Hypoxia‐induced Cerebral Oedema and Inflammation Through the NF‐κB/VEGF/MMP‐9 Pathway

Expression of Aquaporin-1 and Aquaporin-5 in a Rat Model of High-Altitude Pulmonary Edema and the Effect of Hyperbaric Oxygen Exposure

Protective Effect of 5,6,7,8-Tetrahydroxyflavone on High Altitude Cerebral Edema in Rats.

Expression profile of cytokines and chemokines in a mouse high-altitude cerebral edema model

A Multimodal MR Imaging Study of the Effect of Hippocampal Damage on Affective and Cognitive Functions in a Rat Model of Chronic Exposure to a Plateau Environment